Generic OxyContin would be 'tragedy,' Ont. health minister says
News | 13 November 2012
With the powerful painkiller's patent set to expire in just over a week, Ontario's health minister says it will be a ?tragedy? if drug companies are given permission to sell generic versions of OxyContin in Canada. Deb Matthews, along with other ...
Click on the link to read the full article at CTV News
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
